Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study.

Zhou AW, Teagle GM, Baumann LM, Cao JA, Emanuelli A, Hu AY, Berger AS, Major JC, Lee SY, Huddleston SM, Gonzalez VH, Clark WL, Liao DS, Kingsley RM, Lazarus HS, Payne JF, Feinstein EG, Meleth AD, Patel SB, Fan KC, Berliner AJ, Moini H, Niu X, Ip MS, Sadda SR, Al-Khersan H, Wykoff CC.

Open source

DOI: 10.3390/jpm15110555
Published: 2025-11-14
Container: J Pers Med
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jpm15110555,
  title = {Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study.},
  author = {Zhou AW and  Teagle GM and  Baumann LM and  Cao JA and  Emanuelli A and  Hu AY and  Berger AS and  Major JC and  Lee SY and  Huddleston SM and  Gonzalez VH and  Clark WL and  Liao DS and  Kingsley RM and  Lazarus HS and  Payne JF and  Feinstein EG and  Meleth AD and  Patel SB and  Fan KC and  Berliner AJ and  Moini H and  Niu X and  Ip MS and  Sadda SR and  Al-Khersan H and  Wykoff CC.},
  year = {2025},
  journal = {J Pers Med},
  doi = {10.3390/jpm15110555},
  url = {https://doi.org/10.3390/jpm15110555}
}

RIS

TY  - JOUR
TI  - Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study.
AU  - Zhou AW
AU  -  Teagle GM
AU  -  Baumann LM
AU  -  Cao JA
AU  -  Emanuelli A
AU  -  Hu AY
AU  -  Berger AS
AU  -  Major JC
AU  -  Lee SY
AU  -  Huddleston SM
AU  -  Gonzalez VH
AU  -  Clark WL
AU  -  Liao DS
AU  -  Kingsley RM
AU  -  Lazarus HS
AU  -  Payne JF
AU  -  Feinstein EG
AU  -  Meleth AD
AU  -  Patel SB
AU  -  Fan KC
AU  -  Berliner AJ
AU  -  Moini H
AU  -  Niu X
AU  -  Ip MS
AU  -  Sadda SR
AU  -  Al-Khersan H
AU  -  Wykoff CC.
PY  - 2025
JO  - J Pers Med
DO  - 10.3390/jpm15110555
UR  - https://doi.org/10.3390/jpm15110555
ER  -

APA

AW, Z., GM, T., LM, B., JA, C., A, E., AY, H., AS, B., JC, M., SY, L., SM, H., VH, G., WL, C., DS, L., RM, K., HS, L., JF, P., EG, F., AD, M., SB, P., KC, F., AJ, B., H, M., X, N., MS, I., SR, S., H, A., & CC., W. (2025). Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study.. J Pers Med. https://doi.org/10.3390/jpm15110555

Source records

europe-pmc · retrieved 2026-09-24T21:04:09.831Z